Inactive Instrument

Viela Bio, Inc.

Equities

VIE

US9266131005

Biotechnology & Medical Research

Aaron Ren Steps Down as Senior Vice President, Head of Business Development and Operations of Viela Bio, Inc., Effective December 31, 2020

December 08, 2020 at 04:10 pm

On December 7, 2020, Aaron Ren, Ph.D., stepped down from his position as Senior Vice President, Head of Business Development and Operations of Viela Bio, Inc., effective as of the end of day on December 31, 2020.

Latest news about Viela Bio, Inc.

AstraZeneca : Closes $775 Million Sale of Stake in US-Based Viela Bio	21-03-16	MT
Horizon Therapeutics Public : Completes Viela Bio Acquisition	21-03-15	MT
Viela Bio, Inc. Announces Board Changes	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from S&P TMI Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from S&P Biotechnology Select Industry Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from S&P Global BMI Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from Russell 2000 Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from Russell 3000 Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from Russell 2500 Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from Russell 2000 Growth Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from Russell Small Cap Completeness Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from Russell Small Cap Comp Growth Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from Russell 3000 Growth Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from Russell 2500 Growth Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from Russell 3000E Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from Russell 3000E Growth Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from Russell 2000 Dynamic Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from Russell 2500 Dynamic Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from Russell 2000 Growth-Dynamic Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from Russell 2500 Growth-Dynamic Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from NASDAQ Composite Index	21-03-15	CI
Horizon Therapeutics USA, Inc. completed the acquisition of Viela Bio, Inc. from AstraZeneca UK Limited and others.	21-03-14	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from NASDAQ Biotechnology Index	21-03-12	CI
Correction: -- Earnings Flash (VIE) VIELA BIO Posts Q4 Revenue $9.4M, vs. Street Est of $5.55M	21-03-01	MT
Viela Bio : Q4 Loss Widens; Revenue Tops Consensus	21-03-01	MT

Chart Viela Bio, Inc.

Duration

Period

More charts

Company Profile

Viela Bio Inc. is a clinical-stage biotechnology company. The Company is focused on developing treatments for severe inflammation and autoimmune diseases. Its product pipeline includes Inebilizumab, VIB4920 and VIB7734. Inebilizumab is a humanized mAb that binds to and depletes CD19+ B cells including plasmablasts and plasma cells. VIB4920 is a fusion protein designed to bind to CD40 ligand (CD40L) on activated T cells, blocking the interaction with CD40 expressed on B cells and preventing them from differentiating into plasma cells and memory B cells. VIB7734 is a treatment for autoimmune and related inflammatory diseases.

Sector

Biotechnology & Medical Research

More about the company

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
REGENERON PHARMACEUTICALS, INC.	+11.60%	106B
BIONTECH SE	-4.68%	24.28B
ARGENX SE	-0.26%	21.96B
GENMAB A/S	-8.63%	18.16B
WUXI APPTEC CO., LTD.	-42.12%	16.37B
BEIGENE, LTD.	-17.47%	15.56B
NEUROCRINE BIOSCIENCES, INC.	+2.77%	13.63B
SAREPTA THERAPEUTICS, INC.	+34.58%	12.27B
INSMED INCORPORATED	+77.64%	8.87B

Bio Therapeutic Drugs